The global surgical robotics market size was estimated to be USD 9.44 billion in 2023 and is expected to reach USD 50.38 billion by 2034 with a CAGR of 16.44% during the forecast period 2024-2034. The market will expand due to the benefits of minimally invasive surgery, the growing need for MIS operations, the supportive healthcare environment, cost-effectiveness, and return on investment.
Better patient outcomes result from surgeons using surgical robots to do treatments with more control and accuracy, particularly in small areas. Smaller incisions are typically used in minimally invasive operations, which reduces blood loss and promotes quicker healing and shorter hospital stays. For instance, Intuitive Surgical and Medtronic announced a strategic agreement in January 2024 to jointly develop and commercialize next-generation robotic technologies.
By surgery type, the general surgery segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the increasing adoption of robotic-assisted procedures for a wide range of general surgery applications, including minimally invasive surgeries, cholecystectomy, hernia repair, and colorectal surgery. For instance, in October 2023, Stryker Corporation received the CE Mark for their Senhance Flex system, a robotic platform that is flexible and may be used for thoracic and laparoscopic operations. Additionally, the orthopedic surgery segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of orthopedic conditions, such as joint disorders and musculoskeletal injuries, which necessitate surgical interventions.
By component, the systems segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the continuous technological advancements and the widespread adoption of advanced surgical systems, such as the Da Vinci Surgical System and other robotic platforms. For instance, in Dec 2023, Medtronic acquired Auris Health to extend its foothold in thoracic robotics and obtain access to the Monarch platform for lung cancer surgery. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the. growing recognition of the importance of comprehensive support services for maintaining, upgrading, and optimizing surgical robotic systems.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the growing adoption of surgical robotics for a diverse range of medical procedures and the increasing preference of hospitals for advanced technologies to enhance patient care. For instance, in September 2023, Johnson & Johnson (Ethicon) partnered with Verily Life Sciences to create artificial intelligence (AI) driven equipment for robotic surgery applications. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the. the increasing trend towards outpatient surgical procedures and the growing recognition of the benefits offered by surgical robotics in enhancing efficiency and patient outcomes in ambulatory settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high adoption rate of advanced medical technologies, significant investments in healthcare infrastructure, and a well-established regulatory framework supporting the integration of surgical robotics. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of advanced medical technologies, rising healthcare investments, and a growing demand for minimally invasive surgical procedures. For instance, Verb Surgical's single-port robotic surgical platform, intended for enhanced minimally invasive access, received FDA authorization in August 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Better patient outcomes result from surgeons using surgical robots to do treatments with more control and accuracy, particularly in small areas. Smaller incisions are typically used in minimally invasive operations, which reduces blood loss and promotes quicker healing and shorter hospital stays. For instance, Intuitive Surgical and Medtronic announced a strategic agreement in January 2024 to jointly develop and commercialize next-generation robotic technologies.
By surgery type, the general surgery segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the increasing adoption of robotic-assisted procedures for a wide range of general surgery applications, including minimally invasive surgeries, cholecystectomy, hernia repair, and colorectal surgery. For instance, in October 2023, Stryker Corporation received the CE Mark for their Senhance Flex system, a robotic platform that is flexible and may be used for thoracic and laparoscopic operations. Additionally, the orthopedic surgery segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of orthopedic conditions, such as joint disorders and musculoskeletal injuries, which necessitate surgical interventions.
By component, the systems segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the continuous technological advancements and the widespread adoption of advanced surgical systems, such as the Da Vinci Surgical System and other robotic platforms. For instance, in Dec 2023, Medtronic acquired Auris Health to extend its foothold in thoracic robotics and obtain access to the Monarch platform for lung cancer surgery. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the. growing recognition of the importance of comprehensive support services for maintaining, upgrading, and optimizing surgical robotic systems.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global surgical robotics market in 2023 owing to the growing adoption of surgical robotics for a diverse range of medical procedures and the increasing preference of hospitals for advanced technologies to enhance patient care. For instance, in September 2023, Johnson & Johnson (Ethicon) partnered with Verily Life Sciences to create artificial intelligence (AI) driven equipment for robotic surgery applications. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the. the increasing trend towards outpatient surgical procedures and the growing recognition of the benefits offered by surgical robotics in enhancing efficiency and patient outcomes in ambulatory settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high adoption rate of advanced medical technologies, significant investments in healthcare infrastructure, and a well-established regulatory framework supporting the integration of surgical robotics. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of advanced medical technologies, rising healthcare investments, and a growing demand for minimally invasive surgical procedures. For instance, Verb Surgical's single-port robotic surgical platform, intended for enhanced minimally invasive access, received FDA authorization in August 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Surgery Type, Component, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Surgical Robotics Market Report 2023 - 2034
Surgical Robotics Market Analysis & Forecast by Surgery Type 2023 - 2034 (Revenue USD Bn)
- General Surgery
- Urology Surgery
- Gynecology Surgery
- Orthopedic Surgery
- Neurosurgery
- Other Surgeries
Surgical Robotics Market Analysis & Forecast by Component 2023 - 2034 (Revenue USD Bn)
- Systems
- Accessories
- Services
Surgical Robotics Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgery Centers
- Other Users
Surgical Robotics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Surgical Robotics Market: Surgery Type Estimates & Trend Analysis
8. Surgical Robotics Market: Component Estimates & Trend Analysis
9. Surgical Robotics Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Surgical Robotics Market
12. Europe Global Surgical Robotics Market
13. Asia Pacific Global Surgical Robotics Market
14. Latin America Global Surgical Robotics Market
15. MEA Global Surgical Robotics Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Intuitive Surgical Inc.
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson (Ethicon)
- Zimmer Biomet Holdings Inc.
- Verb Surgical
- Accuray Incorporated
- TransEnterix Surgical Inc.
- Mazor Robotics Ltd. (Acquired by Medtronic in 2018)
- Smith & Nephew plc
- Renishaw plc
- Hansen Medical Inc. (Acquired by Auris Health)
- Titan Medical Inc.
- CMR Surgical Ltd.
- Microbot Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 9.44 Billion |
| Forecasted Market Value ( USD | $ 50.38 Billion |
| Compound Annual Growth Rate | 16.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
